HomeHealthcare & Life SciencesPharmaceuticals Metformin Hydrochloride Market

North America Metformin Hydrochloride Market Size & Outlook, 2025-2033


North America Metformin Hydrochloride Market Insights

  • Based on Reed Intelligence findings, the North America Metformin Hydrochloride Market size reached USD 7087.2 Million in 2024 and is expected to grow to USD 13008.62 Million by 2033.
  • During 2026–2033, the market is forecasted to advance at a CAGR of 7%.
  • Type 2 Diabetes represented the largest share of the By Indication market in terms of size in 2024.
  • Among the By Indication segments, Polycystic Ovary Syndrome is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • In 2024, North America accounted for 35.33% of the global Metformin Hydrochloride Market size.
  • By 2033, United States is projected to lead the global market in terms of market size.
  • Canada is projected to emerge as the fastest-growing market in North America, reaching USD 3913.55 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 7087.2 Million
Market Size In 2033 USD 13008.62 Million
Largest segment Type 2 Diabetes
Units Revenue in USD Million
CAGR 7% (2025-2033)
Segmnetation Covered
North America
  1. United States
  2. Canada
By Indication
  1. Type 2 Diabetes
  2. Gestational Diabetes
  3. Polycystic Ovary Syndrome
Form
  1. Tablets
  2. Extended-Release Tablets
  3. Oral Solutions
  4. Injectable Solutions
Route of Administration
  1. Oral
  2. Intravenous
Distribution Channel
  1. Retail Pharmacies
  2. Hospital Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports